Oscar Health, Inc. has 2 SEC filings in the last 90 days, latest: Thrive Capital reshuffles 12.1% Oscar Health stake among affiliated funds (13D/A, September 19, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
At its 2026 Investor Day, Oscar Health raised full-year 2026 earnings from operations guidance by $100 million and improved its medical loss ratio outlook by 50 basis points, while reaffirming revenue.
Thrive Capital funds and Joshua Kushner moved Class B shares into other Thrive vehicles and distributed Class A stock to limited partners, leaving total beneficial ownership unchanged at 12.1%.